TETRAHYDROCANNABIVARIN (THC) FOR USE IN THE PROTECTION OF PANCREATIC ISLET CELLS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20140335208A1
SERIAL NO

14358861

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the phytocannabinoid tetrahydrocannabivarin (THCV) for use in the protection of pancreatic islet cells. Preferably the pancreatic islet cells to be protected are beta cells. More preferably the protection of the pancreatic islet cells maintains insulin production at levels which are able to substantially control or improve control of blood glucose levels in a patient.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • GW PHARMA LIMITED

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cawthorne, Michael Buckingham, GB 4 134
Stott, Colin Salisbury, GB 22 689
Wright, Stephen Salisbury, GB 109 3375

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation